Literature DB >> 12768541

Adrenal neuropeptides: regulation and interaction with ACTH and other adrenal regulators.

E J Whitworth1, O Kosti, D Renshaw, J P Hinson.   

Abstract

It is now well accepted that both the cortex and medulla of the mammalian adrenal gland receive a rich innervation. Many different transmitter substances have been identified in nerves supplying both cortex and medulla and, as well as catecholamines, a wide range of neuropeptides has been found in the adrenal gland. There have been several studies on the affects of age, sodium intake, stress, ACTH, and splanchnic nerve activity on the regulation of adrenal neuropeptide content. There is evidence that the abundance of each of these peptides is actively regulated. Although there have been many studies addressing the individual actions of various neurotransmitters on steroid secretion, adrenal blood flow, and adrenal growth, few have attempted to determine the nature of any interaction between neurotransmitters and the classical adrenal stimulants. There are, however, some significant interactions, particularly in the regulation of zona glomerulosa function. This review necessarily focuses on vasoactive intestinal peptide (VIP) and neuropeptide Y (NPY), as these are the most abundant transmitter peptides in the adrenal gland and the majority of studies have investigated their regulation and actions. However, substance P, calcitonin gene-related peptide (CGRP), neurotensin, and the enkephalins are included where appropriate. Finally, it has been suggested that certain neurotransmitters, particularly VIP, may interact with classical hormone receptors in the adrenal, notably the ACTH receptor. This review attempts to evaluate our current state of knowledge in each of these areas. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12768541     DOI: 10.1002/jemt.10335

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  6 in total

Review 1.  Neurotensin agonists: potential in the treatment of schizophrenia.

Authors:  Mona Boules; Amanda Shaw; Paul Fredrickson; Elliott Richelson
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 2.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.

Authors:  Marni N Silverman; Brad D Pearce; Christine A Biron; Andrew H Miller
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

Review 3.  Neuropeptidomic components generated by proteomic functions in secretory vesicles for cell-cell communication.

Authors:  Vivian Hook; Steven Bark; Nitin Gupta; Mark Lortie; Weiya D Lu; Nuno Bandeira; Lydiane Funkelstein; Jill Wegrzyn; Daniel T O'Connor; Pavel Pevzner
Journal:  AAPS J       Date:  2010-08-24       Impact factor: 4.009

4.  Epimedium flavonoids counteract the side effects of glucocorticoids on hypothalamic-pituitary-adrenal axis.

Authors:  Jianhua Huang; Jijun Li; Songbai Zheng; Junzhen Wu; Wei Zhang; Tao Sun; Sheilesh Kumar Dewan; Bill Kalionis; Ziyin Shen; Xiantao Tai; Shijin Xia
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-23       Impact factor: 2.629

Review 5.  Functional Zonation of the Adult Mammalian Adrenal Cortex.

Authors:  Gavin P Vinson
Journal:  Front Neurosci       Date:  2016-06-15       Impact factor: 4.677

Review 6.  Comparative Effect of ACTH and Related Peptides on Proliferation and Growth of Rat Adrenal Gland.

Authors:  Claudimara Ferini Pacicco Lotfi; Pedro O R de Mendonca
Journal:  Front Endocrinol (Lausanne)       Date:  2016-05-09       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.